EXX5:XETRA:XETRA-iShares Dow Jones U.S. Select Dividend UCITS ETF (DE) EUR (EUR)

ETF | Others |

Last Closing

USD 82.84

Change

-1.11 (-1.32)%

Market Cap

USD 0.37B

Volume

2.07K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.52 (-1.14%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.25 (-0.25%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.28 (-1.19%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.15 (-1.14%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.06 (-1.10%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.31 (-1.30%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.03 (-0.23%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-1.32 (-2.33%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.09 (-0.90%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.12 (-0.10%)

USD 12.26B

ETFs Containing EXX5:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.21% 13% F 15% F
Dividend Return -12.30% 55% F 20% F
Total Return -20.51% 6% D- 7% C-
Trailing 12 Months  
Capital Gain 0.62% 31% F 36% F
Dividend Return -12.18% 56% F 13% F
Total Return -11.56% 12% F 17% F
Trailing 5 Years  
Capital Gain 68.55% 60% D- 61% D-
Dividend Return -5.38% 76% C+ 16% F
Total Return 63.17% 57% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 12.46% 77% C+ 75% C
Dividend Return 13.74% 81% B- 78% C+
Total Return 1.28% 81% B- 58% F
Risk Return Profile  
Volatility (Standard Deviation) 17.58% 23% F 36% F
Risk Adjusted Return 78.15% 69% C- 73% C
Market Capitalization 0.37B 67% D+ 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.